Compounds > sulfan blue
Page last updated: 2024-08-18

sulfan blue and Carcinoma, Lobular

sulfan blue has been researched along with Carcinoma, Lobular in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barneveld, PC; Bavelaar-Croon, CD; Bosscha, K; Contant, CM; de Roos, WK; van la Parra, RF1
Inaji, H; Inoue, T; Nakano, Y; Nishi, T; Nishimae, A; Sawai, Y; Yamasaki, M1
Elder, EE; French, J; Kilby, CJ; Ngui, NK; Pathmanathan, N1
Frangioni, JV; Hutteman, M; Liefers, GJ; Lowik, CW; Mieog, JS; Schaafsma, BE; Vahrmeijer, AL; van de Velde, CJ; van der Vorst, JR; Verbeek, FP1
Chhabra, A; Goyal, A; Mansel, RE; Newcombe, RG1
Clough, KB; Falcou, MC; Fréneaux, P; Guilbert, S; Nos, C; Salmon, RJ1

Trials

3 trial(s) available for sulfan blue and Carcinoma, Lobular

ArticleYear
Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Journal of surgical oncology, 2016, Volume: 113, Issue:7

    Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Prospective Studies; Rosaniline Dyes

2016
Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
    Annals of surgical oncology, 2012, Volume: 19, Issue:13

    Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Indocyanine Green; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organotechnetium Compounds; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Spectroscopy, Near-Infrared

2012
Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Breast cancer research and treatment, 2006, Volume: 99, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; False Negative Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Rosaniline Dyes; Sentinel Lymph Node Biopsy; Technetium Tc 99m Aggregated Albumin

2006

Other Studies

3 other study(ies) available for sulfan blue and Carcinoma, Lobular

ArticleYear
A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2014, Volume: 40, Issue:10

    Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; False Negative Reactions; Feasibility Studies; Female; Humans; Lymph Node Excision; Lymph Nodes; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2014
Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Breast cancer (Tokyo, Japan), 2016, Volume: 23, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Axilla; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Coloring Agents; Female; Fluorescence; Follow-Up Studies; Humans; Image-Guided Biopsy; Immunoenzyme Techniques; Indocyanine Green; Lymph Nodes; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2016
Sentinel lymph node detection for breast cancer: which patients are best suited for the patent blue dye only method of identification?
    Annals of surgical oncology, 2001, Volume: 8, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Clinical Competence; Coloring Agents; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Quality Control; Rosaniline Dyes; Sentinel Lymph Node Biopsy

2001